5 January 2021
Primary Health Properties PLC
("PHP" or the "Company")
Completion of internalisation
Further to the announcement on 4 January 2021 in relation to General Meeting to approve the proposed management internalisation, the Company is pleased to announce that the transaction has today completed. Accordingly, Harry Hyman (formerly Managing Director) has been appointed as Chief Executive Officer and Richard Howell (formerly Finance Director) has been appointed as Chief Financial Officer. Paul Wright has been appointed as Company Secretary in place of Nexus Management Services Limited.
As a result of completion 11,485,080 new Ordinary Shares ("New Shares") have been issued to Mr Harry Hyman pursuant to the terms of the Share Purchase Agreement, subject to admission to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE (together, "Admission").
Admission of the New Shares is expected to be effective on 6 January 2021. Following admission and in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, the Company will have 1,327,036,460 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any shares in treasury.
The above figure of 1,327,036,460 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.
Legal Entity Identifier: 213800Y5CJHXOATK7X11
For further information contact:
| Primary Health Properties PLC Steven Owen, Chairman Paul Wright, Company Secretary
| 020 7451 7050 |
| Numis Securities Limited (Joint Sponsor, Financial Adviser and Broker) James Black / Kevin Cruickshank / Huw Jeremy
| 020 7260 1000 |
| Peel Hunt LLP (Joint Sponsor, Financial Adviser and Broker) Capel Irwin / Carl Gough / Harry Nicholas
| 020 7418 8900 |
| Buchanan David Rydell / Steph Watson / Tilly Abraham | 0207 466 5066 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
